Kymera Therapeutics COO Jeremy Chadwick resigns effective June 5, 2026; will advise through Nov 2026

Kymera Therapeutics, Inc.

COO Jeremy Chadwick resigned for personal reasons, not due to any disagreement with company policies.
Chadwick will remain as an employee advisor until November 2026.
No replacement COO has been named by the company.
Chadwick communicated his intention to retire and submitted resignation on June 5, 2026.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeremy Chadwick

Chief Operating Officer

KYMR · Kymera Therapeutics, Inc.

Effective: 2026-06-05
Filed: June 8, 2026, 4:05 PM ET

Jeremy Chadwick communicated his intention to retire and submitted his resignation as Chief Operating Officer (“COO”) on June 5, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeremy Chadwick resigned as Chief Operating Officer at Kymera Therapeutics, Inc..

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

Jeremy Chadwick communicated his intention to retire and submitted his resignation as Chief Operating Officer (“COO”) on June 5, 2026.

View on SEC.gov

Kymera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-261698

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.